Clinical Trial Supply & Logistics Market Analysis | CMI - PowerPoint PPT Presentation

About This Presentation

Clinical Trial Supply & Logistics Market Analysis | CMI


Read here the latest updates on the Clinical Trial Supply & Logistics Market published by CMI team – PowerPoint PPT presentation

Number of Views:56


Transcript and Presenter's Notes

Title: Clinical Trial Supply & Logistics Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Clinical Trial Supply and Logistics Market, By
    Service (Manufacturing, Packaging and Labeling,
    and Distribution), By End User (Pharmaceutical,
    Medical Devices, and Biologics), and by Region -
    Global Forecast to 2026
  • The global clinical trial supply and logistics
    market size was valued at US 14.95 Bn in 2017
    and is expected to witness a CAGR of 7.1 over
    the forecast period (2018 2026).

Fig Global Clinical Trial Supply and Logistics
Market, By Region (US Mn)
Market Drivers
  • Quantity of ancillary supplies and diverse
    vendors to produce those supplies have
    significantly increased in the market, owing to
    rising demand for developing and producing
    clinical supplies from end user manufacturers or
    investigators for global studies in a
    cost-efficient manner. According to an article
    published in the Applied Clinical Trials website,
    2016, there are around 40,000 unique
    investigators worldwide conducting at least one
    FDA-regulated clinical trial. Furthermore,
    increasing prevalence of cancer across the globe
    is providing new opportunities for global
    biopharmaceutical research community, and
    clinical trial supply and logistics management to
    bring the respective drug to the market sooner by
    navigating the complex clinical regulatory
    environment. According to the World Health
    Organization (WHO), there were around 555,318 new
    cases of cancer in 2012 in the Middle East. The
    region is expected to witness around 961,098
    cases by 2030, which will be the highest number
    of cancer cases among other regions in the world.

  • Change in regulations related to clinical trials
    is also expected to have some impact on the
    market. In 2013, the European Union enacted good
    distribution practices (GDPs), which are now
    becoming a globally adopted guidance. Although
    the timeline is still under discussion, new
    regulations for clinical trials that are
    conducted in the European Union will be revealed
    in 2019. The new regulations could potentially
    impact the supply chain, although it is primarily
    geared to existing good manufacturing practices
    (GMPs) for products covered by an existing
  • Biologics are also expected to witness steady
    growth, owing to increasing research activities
    such as development of nanoparticle-based drug
    delivery systems in the field of genetics and
    biotechnology. For instance, in May 2018,
    Catalent Pharma Solutions collaborated with
    Valerius Biopharma AG, a Swiss biopharmaceutical
    company, for the development and manufacturing of
    Valerius biosimilar products, as alternatives to
    high-priced biologics. This is expected to boost
    Clinical Trial Supply and Logistics Market growth
    over the forecast period.

Clinical Trial Supply and Logistics Market
Regional Outlook
  • On the basis of region, the global clinical trial
    supply and logistics market is segmented into
    North America, Europe, Asia Pacific, Latin
    America, Middle East, and Africa.
  • North America is expected to hold a dominant
    position in this market, owing to the adoption of
    technologically advanced products, well
    established regulatory agencies, and presence of
    major Contract Research Organizations (CROs) and
    biopharmaceutical companys hubs. Moreover,
    factors such as improved healthcare facilities
    and better reimbursement scenario are also
    driving growth of clinical trial supply and
    logistics market in this region.
  • The number of new vendors trying to enter the
    healthcare industry are expected to increase over
    the forecast period, as there are many niche
    market players trying to leverage the market
    share through new inventories in medical devices
    and drugs. Also, they will require clinical trial
    supply management to cut down costs across all
    aspects of the business, by reducing internal
    capacity - in terms of site maintenance and
    employee headcount. Thus, emerging economies such
    as Asia Pacific and Latin America has huge
    potential for market growth, and is projected to
    be the fastest growing region over the forecast

Key Players
  • Some of the key players operating in the global
    clinical trial supply and logistics market
    include Catalent Pharma Solutions, Inc., Almac
    Group, Movianto, Patheon, Inc., PCI Pharma
    Distribution, Sharp Packaging Distribution,
    PAREXEL International Corporation, Marken, KLIFO
    A/S, and Biocair.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//
Write a Comment
User Comments (0)